Skip to content

Massage therapy for pediatric adenoid hypertrophy based on the theory of "simultaneous treatment of lung and spleen" Clinical efficacy study

Massage therapy for pediatric adenoid hypertrophy based on the theory of "simultaneous treatment of lung and spleen" Clinical efficacy study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000308
Enrollment
Unknown
Registered
2024-08-27
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenoidal hypertrophy

Interventions

Observers:Tuina technique and Mometasone Furoate Aqueous Nasal Spray

Sponsors

Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) Outpatient cases diagnosed with adenoid hypertrophy that meet the diagnostic criteria of Western medicine; (2) Children aged 3-12 years old; (3) The child and their family members have a high willingness and compliance to cooperate and can cooperate with massage and medication treatment and complete follow-up after recovery.

Exclusion criteria

Exclusion criteria: (1) Individuals with a history of drug allergies and psychiatric disorders; (2) Acute upper respiratory tract infection patients; (3) Patients with acute suppurative or non suppurative otitis media; (4) Patients with severe OSAHS and bronchial allergic asthma; (5) Individuals with severe systemic diseases such as cardiovascular liver kidney or hematopoietic systems; (6) Individuals with other diseases that cause respiratory distress such as obesity nasal polyps severe nasal septum deviation nasopharyngeal tumors airway neuromuscular tension laryngeal and tracheal malformations etc; (7) Individuals who have undergone adenoidectomy or received other medication treatments within the past 2 weeks.

Design outcomes

Primary

MeasureTime frame
OSA-18 scale; Main symptom scoring table;

Secondary

MeasureTime frame
Secondary symptom scoring table;Adenoid A/N ratio;

Countries

China

Contacts

Public ContactYu Yifeng

Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital

13262983975@163.com13262983975

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026